Fujifilm, with $100M Cell Therapy plant buy from Atara
Summary : On his company’s recent spending spree to build manufacturing capacity, Fujifilm Diosynth CEO Martin Meeson said three months ago: “We’re…
Summary : On his company’s recent spending spree to build manufacturing capacity, Fujifilm Diosynth CEO Martin Meeson said three months ago: “We’re…
Synopsis: In June, globe-trotting contract manufacturer Fujifilm Diosynth Biotechnologies unveiled an $850 million outlay to boost biologics capacity in the U.S. and…